Zheyuan Technology, a Beijing-based company, has secured nearly 200 million RMB in its A2 funding round, with lead investment from Shengxiang Bio and its industry fund. The company plans to use these funds for intellectual property development, global asset deployment, and upgrading its AI4S platform driven by life world models. Meanwhile, a CITIC Securities report suggests that the AI
RANK_REASON [lever_c_demoted from research: ic=1 ai=1.0]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
